博士論文

Development of engineered T cells expressing a chimeric CD16-CD3ζ receptor to improve the clinical efficacy of mogamulizumab therapy against adult T-cell leukemia

Icons representing 博士論文
The cover of this title could differ from library to library. Link to Help Page

Available in National Diet Library

Find on the publisher's website

国立国会図書館デジタルコレクション

Digital data available

Check on the publisher's website

DOI[10.1158/1078-0432.CCR-15-2714]to the data of the same series

Development of engineered T cells expressing a chimeric CD16-CD3ζ receptor to improve the clinical efficacy of mogamulizumab therapy against adult T-cell leukemia

Persistent ID (NDL)
info:ndljp/pid/10982674
Material type
博士論文
Author
田中, 寛希
Publisher
田中, 寛希
Publication date
2016
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
愛媛大学,博士(医学)
View All

Notes on use at the National Diet Library

Search by Bookstore

Search by Bookstore

Read this material in an accessible format.

View materials in accessible formats for people with print disabilities (1Type)

Search by Bookstore

Read in Disability Resources

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Title
Development of engineered T cells expressing a chimeric CD16-CD3ζ receptor to improve the clinical efficacy of mogamulizumab therapy against adult T-cell leukemia
Author/Editor
田中, 寛希
Publication, Distribution, etc.
田中, 寛希
Publication Date
2016
Publication Date (W3CDTF)
2016
Alternative Title
成人T細胞白血病に対するmogamulizumab療法の臨床的有効性を改善するキメラ型CD16-CD3ζレセプターを発現させた遺伝子改変T細胞の開発
Degree grantor/type
愛媛大学
Date Granted
2016-09-08
Date Granted (W3CDTF)
2016-09-08